Today we strengthen our partnership with Oslo University Hospital and the Radiation Biology Institute, through a collaboration aimed at enhancing the mechanistic understanding of #Pb212-based #radiopharmaceuticals. This partnership expands our existing support of two graduate students for their PhD research. This partnership will be enabled by our collective expertise to advance the research and development of #alpha #radioligandtherapy (#ART) in #cancer treatment. We are very excited to move the field forward through crucial research and development. Read more here: https://lnkd.in/ggBAwiF8 #RLT #prostatecancer #nuclearmedicine #biotech
ARTBIO’s Post
More Relevant Posts
-
🔬Automating protocols for capturing and immunolabelling breast cancer cells is easy with Fluigent’s Aria. The process involves: ✅Surface treatment ✅Injection of antibody-coated beads and cell suspension ✅Immunostaining protocols 👀 Check out this application note, made in collaboration with Emile Lakis, PhD, from Institut Curie's, Team MMBM (Macromolecules and Microsystems in Biology and Medicine), using an EPHESIA microfluidic chip. Adapt your protocol and make use of the Aria’s specific features to optimize your experiment! ⚙️ 👉Read application note here: https://bit.ly/3TgUz1U 👉Learn more about Aria here: https://bit.ly/4a3AK4l #Aria #Microfluidic #Antibody #InstitutCurie
To view or add a comment, sign in
-
-
The proteomics of tumors is such a hot topic these days! Register now to learn more!
🔬 Exciting News! Join us for our upcoming webinar: "Detecting Growing Tumors through Changes in Plasma Proteome," featuring Dr. Nebojsa Janjic, Chief Science Officer at SomaLogic. 📅 Date: April 22 ⏰ Time: 8:00 am PT, 11:00 am ET This webinar will spotlight findings from Dr. Janjic’s paper, published by @ Springer Nature, which was featured as one of Top 100 downloaded cancer papers from Scientific Reports in 2023! 🎉 In this session, Dr. Janjic will delve into the fascinating world of plasma proteome analysis and its pivotal role in early tumor detection. Don't miss out on this opportunity to gain insights for your research! Register now: https://lnkd.in/gjUvtZW6 #PlasmaProteome #TumorDetection #Proteomics University of Colorado School of Medicine
To view or add a comment, sign in
-
-
This will be an interesting webinar! Register now below!
🔬 Exciting News! Join us for our upcoming webinar: "Detecting Growing Tumors through Changes in Plasma Proteome," featuring Dr. Nebojsa Janjic, Chief Science Officer at SomaLogic. 📅 Date: April 22 ⏰ Time: 8:00 am PT, 11:00 am ET This webinar will spotlight findings from Dr. Janjic’s paper, published by @ Springer Nature, which was featured as one of Top 100 downloaded cancer papers from Scientific Reports in 2023! 🎉 In this session, Dr. Janjic will delve into the fascinating world of plasma proteome analysis and its pivotal role in early tumor detection. Don't miss out on this opportunity to gain insights for your research! Register now: https://lnkd.in/gjUvtZW6 #PlasmaProteome #TumorDetection #Proteomics University of Colorado School of Medicine
To view or add a comment, sign in
-
-
🥇Check out the Editor's Choice #Article "Melanin and Melanin-Functionalized Nanoparticles as Promising Tools in Cancer Research—A Review" 👥by Iasmina Marcovici, Dorina Coricovac et al. Victor Babeş University of Medicine and Pharmacy, Timişoara 📝Link here: https://lnkd.in/dSbTB_4h ✨The review highlights the potential of melanin, a natural polymeric pigment, as a promising candidate for nanotechnology-based cancer treatment due to its unique physicochemical properties and innate antioxidant, photoprotective, anti-inflammatory, and antitumor effects✨
To view or add a comment, sign in
-
-
🔬 🌟 Update! ⏲ Timing shifted to 4:30 PM Join Prof. Herbert Levine's talk on "The Forever War Against Cancer" at ICTS, Ramanujan Lecture Hall. 📌 Register now or drop in for a groundbreaking discussion! https://bit.ly/sl_mar2024 #cancerresearch #ictstifr #bengaluruevents #ScientificTalk #Cancer #biophysics #biotechnology #medicalphysics
To view or add a comment, sign in
-
-
🌟 Excited to share the publication of our last research in Frontiers in Bioengineering and Biotechnology! 🌟 It's well-known how crucial the mechanics of cancer cells are, but what happens after traditional cancer treatments like radiotherapy? 💡🔬 Our latest study dives into this question, revealing fascinating insights into the effects of ionizing radiation on breast adenocarcinoma cells. Through our research, we've discovered how radiation and substrate stiffness impact cell mechanics, leading to changes in paxillin expression, cytoskeletal stiffness, and cytoplasmic/nuclear morphology. These findings open up new avenues for innovative therapeutic strategies and optimizing radiation therapy. 🚀✨ 📖🔗Curious to learn more? Check out the full article here: https://lnkd.in/df4X7E5S Rocco Mottareale Valeria Panzetta Cecilia Arrichiello Paolo Muto Paolo Netti Mariagabriella Pugliese
To view or add a comment, sign in
-
-
We are pleased to share the latest publication from our laboratory, a result of collaboration between #AssamUniversity and #SahaInstituteofNuclearPhysics. This study investigates the impact of C70 and C60 fullerenes on quinazolinone, specifically in quinazolinone–fulleropyrrolidine nanohybrids. The nanohybrids Q3C70M and Q3C60M exhibit distinct spectral shifts and have significant photobiological antineoplastic properties. Q3C60M enhances apoptosis, while Q3C70M reduces Cyclin A levels and counteracts oncogenic effects by promoting cell differentiation. Q3C70M demonstrates heightened cytotoxicity by overcoming chemotherapy resistance by modulating BAX and BCL-2 levels. This innovative approach, distinguishing between C70 and C60, represents a novel contribution to the existing scientific literature. https://lnkd.in/dBbb9dNx #science #research #cancer #organicchemistry #organicsynthesis #medicinalchemistry #cancerphotodynamictherapy #ACS #ACSMedicinalChemistryLetters #AssamUniversity #SahaInstituteofNuclearPhysics
To view or add a comment, sign in
-
-
It is exciting to witness how bioprinting continues to be an integral tool in cancer research. 🧑🔬👩🔬In a recent study, researchers from the University of California, Los Angeles developed an innovative approach for organoid screening. This method combines bioprinting with high-speed live cell interferometry (HSLCI), a non-invasive and label-free imaging technique that captures time-resolved images of living cells. 🔬By leveraging the BIO X bioprinter, the research team achieved high precision and consistency in controlling the printed constructs' temperature, shape, and size. This level of control greatly facilitated downstream analysis. 🤖Additionally, incorporating machine learning strategies significantly improved image segmentation and track filtering, leading to a substantial increase in the number of organoids that can be effectively tracked. This integrative method addresses previous challenges and paves the way for possible future clinical applications in cancer treatment. Read the full study here: https://ow.ly/Vsnf50PAHnn #bioprinting #organoids #livecellimaging #cancerresearch #analysis #tissueengineering
To view or add a comment, sign in
-
-
Are you a researcher involved in PET tracer development, cancer biology and therapeutics, or a nuclear #imaging specialist? Tune in for the free webinar "Hypoxia in the Tumor Immune Microenvironment (TIME)" on July 11, at 4 PM CEST: https://lnkd.in/diPbuZYc Prof. Zaver M. Bhujwalla, at Johns Hopkins Medicine, will review in vivo (e.g. PET/MR) and cellular and molecular (e.g. MRI/NMR spectroscopy) preclinical studies that provide new insights into varied tumor profiles/types and the underlying interplay in PD-L1 status, hypoxia, and fibroblasts in the tumor microenvironment. Such insights pave the way for improved therapies. #NMR #MRI #PreclinicalImaging #Hypoxia #Oncology
To view or add a comment, sign in
-
The role of immunosuppressive cells in tumor progression significantly influences treatment efficacy and cancer prognosis. Accurate visualisation and real-time evaluation of these cells are crucial for precision oncological medicine. In this this review Bao G, Zhou J, Cheng S, et al from Huazhong University of Science and Technology highlight the importance of noninvasive imaging techniques, discussing recent advancements in molecular imaging probes designed to monitor protumoral immunosuppressive cells within the tumor microenvironment. Read more 👉 https://lnkd.in/efn4E3zW #Immunosuppression #CancerResearch #PrecisionMedicine
To view or add a comment, sign in
-